NCT06366113 (CHRONOBIO) is a NA clinical trial of Pulmonary rehabilitation in Respiratory Diseases, sponsored by Michaël RACODON.

Who is sponsoring NCT06366113?

NCT06366113 is sponsored by Michaël RACODON.

What drugs are being tested in NCT06366113?

Interventions in NCT06366113: Pulmonary rehabilitation.

What condition does NCT06366113 study?

NCT06366113 studies Respiratory Diseases.

Is NCT06366113 still recruiting?

NCT06366113 is currently recruiting now. Last updated 12 January 2026.

Last reviewed 2026-01-12 · How we verify

NCT06366113: CHRONOBIO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD)

Recruiting now NA Last updated 12 January 2026

What this trial tests

NA trial testing Pulmonary rehabilitation in Respiratory Diseases in 90 participants. Currently enrolling.

Timeline

2 January 2024

Primary endpoint
2 January 2024

1 July 2026

Quick facts

Lead sponsor	Michaël RACODON
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	90
Start date	2 January 2024
Primary completion	2 January 2024
Estimated completion	1 July 2026
Sites	1 location across France

Drugs / interventions tested

Pulmonary rehabilitation

Conditions studied

Respiratory Diseases — all drugs for Respiratory Diseases →

Sponsor

Michaël RACODON

Who can join

Adults 18 to 85, any sex, with Respiratory Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pulmonary rehabilitation (PR) is an effective intervention for reducing hospital readmissions, secondary events, and mortality in patients with respiratory pathologies. The program should not be improved by introducing new subjects such as circadian rhythm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pulmonary rehabilitation

Trials testing the same drug.

NCT07088185 — Pulmonary Outcomes on Patients With Lung Fibrosis · NA · active not recruiting
NCT06522724 — Education Impact on Rehabilitation of Hospitalized Patients With Pneumonia and COVID-19 · NA · completed
NCT06028711 — Education Impact on Rehabilitation of Hospitalized Patients with Chronic Obstructive Pulmonary Disease. · NA · completed
NCT06051136 — Early Versus Delayed Rehabilitation Intervention in Patients With Lung Cancer · NA · active not recruiting
NCT06453421 — Pulmonary Rehabilitation in the Chronically Critically Ill Patient · recruiting

Other recruiting trials for Respiratory Diseases

Currently open trials in the same condition.

NCT07090200 — Rehabilitation Intervention for COPD Combined With Cardiovascular and Cerebrovascular Diseases · NA · recruiting
NCT06373939 — Performance and Safety of the Pneumoscope Device in Adults and Children · NA · recruiting
NCT06267859 — Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06366113 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Michaël RACODON
Last refreshed: 12 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06366113.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing